about
A Review on Potential Mechanisms of Terminalia chebula in Alzheimer's DiseaseMemory decline in Down syndrome and its relationship to iPF2alpha, a urinary marker of oxidative stressThe association of oxidative stress and disease activity in seborrheic dermatitis.Intracellular oxidant activity, antioxidant enzyme defense system, and cell senescence in fibroblasts with trisomy 21.Oxidative Stress -a Phenotypic Hallmark of Fanconi Anemia and Down Syndrome: The Effect of AntioxidantsOxidative Stress and Mitochondrial Dysfunction in Down's Syndrome: Relevance to Aging and DementiaOxidative Stress in Cancer-Prone Genetic Diseases in Pediatric Age: The Role of Mitochondrial DysfunctionModular transcriptional repertoire and MicroRNA target analyses characterize genomic dysregulation in the thymus of Down syndrome infants.(1)H-MRS metabolites in adults with Down syndrome: Effects of dementiaAtypical aging in Down syndrome.The regulator of calcineurin (RCAN1) an important factor involved in atherosclerosis and cardiovascular diseases development.HNE-modified proteins in Down syndrome: Involvement in development of Alzheimer disease neuropathology.Disturbance of redox homeostasis in Down Syndrome: Role of iron dysmetabolism.Evaluation of uric acid levels, thyroid function, and anthropometric parameters in Japanese children with Down syndrome.Apoptosis in Down's syndrome: lessons from studies of human and mouse models.On the Origin of Superoxide Dismutase: An Evolutionary Perspective of Superoxide-Mediated Redox Signaling.Age-Related Cortical Thickness Reduction in Non-Demented Down's Syndrome Subjects.Age effects on cortical thickness in young Down's syndrome subjects: a cross-sectional gender study.Chronic Melatonin Administration Reduced Oxidative Damage and Cellular Senescence in the Hippocampus of a Mouse Model of Down Syndrome.Rapamycin Treatment Ameliorates Age-Related Accumulation of Toxic Metabolic Intermediates in Brains of the Ts65Dn Mouse Model of Down Syndrome and Aging
P2860
Q26864964-9E129A94-1696-44F2-896B-3FD10F2BCB4FQ33716691-48B220F1-CC96-42A0-B6B0-D30FD053060BQ34032395-5E6A0838-0748-4E1E-A699-A9F3C797F4FEQ35234195-FA9CFD31-84EF-46A5-8D62-BF0A6B76A9E1Q35681567-61A828F9-7A72-4DCC-8EA6-377712F4D9C8Q35955120-96B7DC97-826D-42B7-880C-DEDF9E42CD6CQ36889828-E7C48134-2D4E-49CC-92DD-B29C35B0EB62Q36946554-560FAA72-07F7-42FA-95AD-CD3D42BD42B2Q37005407-9FB4B385-02AE-484B-B296-701A17EBB3AFQ38129325-70A0480A-B835-408C-8D93-B9B9B50BB638Q38365018-69CA62D6-7484-4FEF-A464-B3155DCDC0D5Q39006663-B405D517-8DCF-488F-8A20-B8713B81DB65Q39433562-50D9309B-E685-4475-A86A-4115DFC6F6CCQ41685491-0D95B585-77FB-466B-AE80-1817BAE34832Q43723779-FFCDD130-3B6B-45E2-95F8-0C8EBB290E27Q46272318-171C15CC-39C4-4CD0-AFD1-DE00ED9D61D6Q48166568-9E0E4696-CB33-445E-81C7-A2919759E3FAQ48390698-4F11FDBA-9320-4319-9427-4B7F7C0BC74FQ48444907-3B181F50-9663-43C0-B490-C9F6C79097D9Q58761442-93CA2B9B-C7EE-4B4A-A2C8-F74DC2E87F0D
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Antioxidants in Down syndrome.
@ast
Antioxidants in Down syndrome.
@en
type
label
Antioxidants in Down syndrome.
@ast
Antioxidants in Down syndrome.
@en
prefLabel
Antioxidants in Down syndrome.
@ast
Antioxidants in Down syndrome.
@en
P2860
P1476
Antioxidants in Down syndrome.
@en
P2093
Ira T Lott
P2860
P304
P356
10.1016/J.BBADIS.2011.12.010
P407
P577
2011-12-21T00:00:00Z